Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 60 Records) |
| Query Trace: Disease and Mos[original query] |
|---|
| Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation. Frontiers in oncology 2021 12 11 739090. Tian Tian, Yu Min, Li Juan, Jiang Maoqiong, Ma Daiyuan, Tang Shubin, Lin Zhiyu, Chen Lin, Gong Youling, Zhu Jiang, Zhou Qiang, Huang Meijuan, Lu Y |
| NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors. European journal of cancer (Oxford, England : 1990) 2021 11 159 113-124. Thielmann Carl M, Chorti Eleftheria, Matull Johanna, Murali Rajmohan, Zaremba Anne, Lodde Georg, Jansen Philipp, Richter Luisa, Kretz Julia, Möller Inga, Sucker Antje, Herbst Rudolf, Terheyden Patrick, Utikal Jochen, Pföhler Claudia, Ulrich Jens, Kreuter Alexander, Mohr Peter, Gutzmer Ralf, Meier Friedegund, Dippel Edgar, Weichenthal Michael, Paschen Annette, Livingstone Elisabeth, Zimmer Lisa, Schadendorf Dirk, Hadaschik Eva, Ugurel Selma, Griewank Klaus |
| Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer. European urology oncology 2021 11 . Alhalabi Omar, Zhu Yueting, Hamza Ameer, Qiao Wei, Lin Yiyun, Wang Raymond M, Shah Amishi Y, Campbell Matthew T, Holla Vijaykumar, Kamat Ashish, Wang Wei-Lien, Wang Jennifer, Chen Jianfeng, Meng Jieru, Zhang Miao, Bondaruk Jolanta, Titus Mark, Genovese Giannicola, Czerniak Bogdan A, Shaw Kenna R, Meric-Bernstam Funda, Guo Charles C, Logothetis Christopher J, Siefker-Radtke Arlene, Msaouel Pavlos, Wang Linghua, Liu Jiyan, Gao Jianj |
| Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma. Journal of cancer research and clinical oncology 2022 8 . Lazaridis Lazaros, Schmidt Teresa, Oster Christoph, Blau Tobias, Pierscianek Daniela, Siveke Jens T, Bauer Sebastian, Schildhaus Hans-Ulrich, Sure Ulrich, Keyvani Kathy, Kleinschnitz Christoph, Stuschke Martin, Herrmann Ken, Deuschl Cornelius, Scheffler Björn, Kebir Sied, Glas Mart |
| The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer. Cancers 2022 7 14 (15): . Nahm Christopher B, Turchini John, Sahni Sumit, Moon Elizabeth, Itchins Malinda, Arena Jennifer, Chou Angela, Colvin Emily K, Howell Viive M, Pavlakis Nick, Clarke Stephen, Samra Jaswinder S, Gill Anthony J, Mittal Anubh |
| Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in EGFR-mutated non-small cell lung cancer: A real-world study. Cancer medicine 2022 Jun . Hu Chunhong, Wu Sixuan, Deng Renfang, Wu Yuanqiang, Pan Yue, Shu Long, Wu Fa |
| Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma. European journal of cancer (Oxford, England : 1990) 2022 Jun 171 232-241. Rimini Margherita, Macarulla Teresa, Burgio Valentina, Lonardi Sara, Niger Monica, Scartozzi Mario, Rapposelli Ilario G, Aprile Giuseppe, Ratti Francesca, Pedica Federica, Verdaguer Helena, Nappo Floriana, Nichetti Federico, Lai Eleonora, Valgiusti Martina, Cappetta Alessandro, Febregat Carles, Fassan Matteo, De Braud Filippo, Puzzoni Marco, Frassineti Giovanni L, Simionato Francesca, De Cobelli Francesco, Aldrighetti Luca, Fornaro Lorenzo, Cascinu Stefano, Casadei-Gardini Andr |
| Safety and efficacy of nivolumab plus recombinant human endostatin in previously treated advanced non-small-cell lung cancer. Translational lung cancer research 2022 3 11 (2): 201-212. Lv Weize, Pei Xiaofeng, Zhao Wenhua, Cong Yunyan, Wei Yajun, Li Ting, Zhang Hongyu, Lin Zhong, Saito Yuichi, Kim Jae Jun, Liang Zibin, Zhong Beilong, Wang Zhih |
| Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS). Clinical lymphoma, myeloma & leukemia 2022 2 22 (7): e467-e476. Chan Onyee, Ali Najla Al, Sallman David, Padron Eric, Lancet Jeffrey, Komrokji Ra |
| Evaluate the Prognosis of MYC/TP53 Comutation in Chinese Patients with EGFR-Positive Advanced NSCLC Using Next-Generation Sequencing: A Retrospective Study. Technology in cancer research & treatment 2022 12 21 15330338221138213. Cao Jin, J Gu Juan, Liang Yichen, Wang Buh |
| The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study. Cancer medicine 2022 11 . Yu Xiaoqing, Si Jinfei, Wei Jingwen, Wang Yanling, Sun Yan, Jin Jianan, Zhang Xiaoyan, Ma Tonghui, Song Zheng |
| The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 7 . Timothy J Brown, Arielle Yablonovitch, Jacob E Till, Jennifer Yen, Lesli A Kiedrowski, Ryan Hood, Mark H O'Hara, Ursina Teitelbaum, Thomas B Karasic, Charles Schneider, Erica L Carpenter, Katherine Nathanson, Susan M Domchek, Kim A Rei |
| Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China. Advances in therapy 2023 6 . Xinhua Zhang, Peng Zhang, Haibo Qiu, Yong Fang, Heli Liu, Yongjian Zhou, Hao Xu, JiRen Yu, Jun Zhang, Ming Wang, Lin Shen, Jian |
| Osimertinib combined with bevacizumab as the first-line treatment in non-small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations. Thoracic cancer 2023 4 . Zhang Ling, You Yunhong, Liu Xueli, Liu Fengjuan, Nie Keke, Ji Youx |
| Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C. Digestive diseases and sciences 2023 2 1-9. Bonkovsky Herbert L, Rudnick Sean P, Ma Christopher D, Overbey Jessica R, Wang Kelly, Faust Denise, Hallberg Csilla, Hedstrom Karli, Naik Hetanshi, Moghe Akshata, Anderson Karl |
| Efficacy and safety of anti-programmed cell death protein 1 antibody combination therapy in patients with advanced experienced epidermal growth factor receptor-tyrosine kinase inhibitor-resistant lung adenocarcinoma: a retrospective cohort study. Journal of thoracic disease 2023 11 15 (10): 5648-5657. Chang Wan, Yiruo Zhang, Pingping Liu, Xinkuan Mei, Gang Cheng, Jingdan Pang, Sheng Chen, Jianping Xu, Jyoti Malhotra, Hesheng Qian, Yingying |
| Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers 2023 1 15 (1): . Peleg Hasson Shira, Hershkovitz Dov, Adar Lyri, Brezis Miriam, Shachar Eliya, Aks Rona, Galmor Lee, Raviv Yuval, Ben Neriah Shira, Merimsky Ofer, Sabo Edmond, Wolf Ido, Safra Tam |
| Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients. Targeted oncology 2023 1 18 (1): 139-145. Rimini Margherita, Fabregat-Franco Carles, Persano Mara, Burgio Valentina, Bergamo Francesca, Niger Monica, Scartozzi Mario, Rapposelli Ilario Giovanni, Aprile Giuseppe, Ratti Francesca, Pedica Federica, Verdaguer Helena, Rizzato Mario, Nichetti Federico, Lai Eleonora, Cappetta Alessandro, Macarulla Teresa, Fassan Matteo, De Braud Filippo, Pretta Andrea, Simionato Francesca, De Cobelli Francesco, Aldrighetti Luca, Fornaro Lorenzo, Cascinu Stefano, Casadei-Gardini Andr |
| Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with leptomeningeal metastases harboring targetable mutations. Translational lung cancer research 2024 8 13 (7): 1695-1707. Xiaoyu Ji, Rongrong Jiang, Tao Liu, Mariano Provencio, Sang Chul Lee, Qiong Zhan, Xinli Zh |
| A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib. Therapeutic advances in medical oncology 2024 8 16 17588359241264730. Yongfeng Yu, Wen Dong, Yanxia Shi, Rong Wu, Qitao Yu, Feng Ye, Chengzhi Zhou, Xiaorong Dong, Xingya Li, Yongsheng Li, Zhen Li, Lin Wu, Yueyin Pan, Hong Shen, Dehua Wu, Zhongyuan Xu, Jinsheng Wu, Nong Xu, Yanru Qin, Aimin Zang, Jingdong Zhang, Jianya Zhou, Xiaotao Zhang, Yanqiu Zhao, Fugen Li, Huizhen Wang, Qi Liu, Zhenyong Han, Jin Li, Shun |
| Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinib. Lung cancer (Amsterdam, Netherlands) 2024 8 195 107926. Adam Barsouk, Omar Elghawy, Alec Heidlauf, Connie Yu, Lucy Wang, David Yang, Martin Kurian, Keshav Goel, Lynn Rushkin, Anna Anran Huang, Lauren Reed-Guy, Benjamin Bleiberg, Lova Sun, Aditi Singh, Roger B Cohen, Charu Aggarwal, Melina Marmarelis, Corey Lang |
| Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor for lung adenosquamous cell carcinoma harboring EGFR mutation: a retrospective study and pooled analysis. Frontiers in oncology 2024 7 14 1354854. Xueming Xia, Wei Du, Yan Zhang, Yanying Li, Min Yu, Yongmei L |
| Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas. European journal of cancer (Oxford, England : 1990) 2024 7 208 114208. Philipp Jansen, Wolfgang Galetzka, Georg C Lodde, Fabian Standl, Anne Zaremba, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Claudia Pföhler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Michael Weichenthal, Jan-Malte Placke, Jennifer Landsberg, Inga Möller, Antje Sucker, Annette Paschen, Eva Hadaschik, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Selma Ugurel, Andreas Stang, Klaus G Griewa |
| Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer. Frontiers in pharmacology 2024 4 15 1331138. Xiaojuan Zhang, Mina Zhang, Xinyang Du, Guowei Zhang, Yuanyuan Niu, Chunhua Wei, Lanwei Guo, Chao Shi, Hangfan Liu, Huijuan Wa |
| Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy. Oncology research 2024 12 33 (1): 45-55. Enrico Caliman, Sara Fancelli, Federico Scolari, Adriano Pasqui, Clara Manneschi, Daniele Lavacchi, Francesca Mazzoni, Francesca Gensini, Valeria Pasini, Camilla Eva Comin, Luca Voltolini, Serena Pillozzi, Lorenzo Antonuz |
| [A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2024 12 46 (11): 1038-1048. J Du, X Qiu, J Y Ni, Q L Wang, F Tong, H Z Sha, Y H Zhu, L Qi, W Cai, C Gao, X W Wei, M B Chen, Z Y Qian, M H Cai, M Tao, C L Wang, G C Zheng, H Jiang, A W Dai, J Wu, M H Zhao, X Q Li, B Lu, C B Wang, B R L |
| Subfoveal Choroidal Thickness in Patients with Histiocytosis and Multimodal Imaging Features of Choroidal Infiltrates. Ophthalmology. Retina 2024 11 . Jasmine H Francis, Anne S Reiner, Julia Canestraro, David H Abramson, Eli L Diamo |
| Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer. Breast cancer research and treatment 2024 1 . Jianxin Zhong, Hanfang Jiang, Xiaoran Liu, Hao Liao, Feng Xie, Bin Shao, Shidong Jia, Huiping |
| Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes in ELN Favorable Risk NPM1-mutated AML. Blood advances 2024 1 . Onyee Chan, Najla H Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad O Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison R Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra L Sweet, Rami S Komrokji, Jeffrey E Lanc |
| A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer. Clinical & translational immunology 2024 1 13 (1): e1483. Mingzhen Zhou, Yuncheng Jin, Sihui Zhu, Chen Xu, Lin Li, Baorui Liu, Jie Sh |
- Page last reviewed:Feb 1, 2024
- Content source: